miun.sePublications
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
The Patient Activation Measure: a validation study in a neurological population
Dalhousie Univ, Sch Occupat Therapy, Halifax, NS B3H 4R2, Canada.
DalhousiDalhousie Univ, Community Hlth & Epidemiol, Halifax, NS B3H 4R2, Canada.
Queens Univ, Sch Rehabil Therapy, Kingston, ON, Canada.
Mid Sweden University, Faculty of Human Sciences, Department of Health Sciences. Dalhousie Univ, Sch Occupat Therapy, Halifax, NS B3H 4R2, Canada.
Show others and affiliations
2015 (English)In: Quality of Life Research, ISSN 0962-9343, E-ISSN 1573-2649, Vol. 24, no 7, 1587-1596 p.Article in journal (Refereed) Published
Abstract [en]

Purpose To assess the validity of the Patient Activation Measure (PAM13) of patient activation in persons with neurological conditions. Methods ‘‘The Everyday Experience of Living with and Managing a Neurological Condition’’ (The LINC study) surveyed 948 adults with neurological conditions residing in Canada in 2011 and 2012. Using data for 722 respondents who met coding requirements for the PAM-13, we examined the properties of the measure using principle components analysis, inter-item correlations and Cronbach’s alpha to assess unidimensionality and internal consistency. Rasch modeling was used to assess item performance and scaling. Construct validity was assessed by calculating associations between the PAM and known correlates. Results PAM-13 provides a suitably reliable and valid instrument for research in patients with neurological conditions, but scaling problems may yield measurement error and biases for those with low levels of activation. This is of particular importance when used in clinical settings or for individual client care. Our study also suggests that measurement of activation may benefit from tailoring items and scaling to specific diagnostic groups such as people with neurological conditions, thus allowing the PAM-13 to recognize unique attributes and management challenges in those conditions. Conclusions The PAM-13 is an internally reliable and valid tool for research purposes. The use of categorical activation ‘‘level’’ in clinical settings should be done with caution.

Place, publisher, year, edition, pages
Springer International Publishing , 2015. Vol. 24, no 7, 1587-1596 p.
Keyword [en]
patient activation, neurological condition, measurements, validation
National Category
Nursing
Identifiers
URN: urn:nbn:se:miun:diva-24685DOI: 10.1007/s11136-014-0908-0ISI: 000356960500003Scopus ID: 2-s2.0-84933279182OAI: oai:DiVA.org:miun-24685DiVA: diva2:797267
Projects
Living with a neurological condition in Canada (LINC)
Available from: 2015-03-23 Created: 2015-03-23 Last updated: 2015-12-22Bibliographically approved

Open Access in DiVA

No full text

Other links

Publisher's full textScopus

Search in DiVA

By author/editor
Audulv, Åsa
By organisation
Department of Health Sciences
In the same journal
Quality of Life Research
Nursing

Search outside of DiVA

GoogleGoogle Scholar

Altmetric score

Total: 53 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf